Lumera Corporation and Plexera Bioscience Announce Speakers at Three Conferences
Lumera zu myNews hinzufügen Was ist das?
Lumera Corporation (NASDAQ:LMRA), a leader in the field of photonic
communications, announced today that Dr. Raluca Dinu, Vice President –
Electro-Optic Business Unit, will speak at the Global Crown Capital
Nanotechnology conference on November 7 in Palo Alto, CA. She is also
scheduled to speak at the 30th Annual Paulson
Investment Westergaard conference in New York on November 13. In both
cases, Dinu will give an overview of Lumera Corporation’s
electro-optic capabilities and products.
Plexera Bioscience LLC, a wholly owned subsidiary of Lumera, announced
that Dr. Joe Vallner, Chairman and CEO of Plexera, will be a speaker at
the Acumen Biofin Rodman & Renshaw 9th
Annual Healthcare conference in New York on November 5. Plexera also
announced that Dr. Timothy Londergan, President and COO, will give an
overview of Plexera at the 30th Annual
Westergaard conference in New York on November 13.
Additional information on the Global Crown conference can be obtained at http://www.globalcrowncapital.com/;
on the Acumen Biofin conference at http://www.rodmanandrenshaw.com/conferences?id=6;
and on the Westergaard conference at http://guest.cvent.com/EVENTS/Info/Summary.aspx?e=a0ddf4ee-9c19-4885-
beb7-63f886c15d33.
About Lumera
Lumera is a leader in the field of photonic communications. The company
designs electro-optic components based on proprietary polymer compounds
for the communications/computing industries. For more information,
please visit www.lumera.com.
About Plexera Bioscience LLC
Plexera Bioscience LLC was established in July of 2007 as a wholly owned
subsidiary of Lumera Corporation (NASDAQ:LMRA) and is focused on
providing the life sciences market with tools, content, and methods to
simplify and accelerate proteomic discovery for therapeutic antibodies
as well as predictive biomarkers.
Certain statements contained in this release are forward-looking
statements that involve a number of risks and uncertainties. Factors
that could cause actual results to differ materially from those
projected in the company's forward-looking statements include the
following: market acceptance of our technologies and products; our
ability to obtain financing; our financial and technical resources
relative to those of our competitors; our ability to keep up with rapid
technological change; government regulation of our technologies; our
ability to enforce our intellectual property rights and protect our
proprietary technologies; the ability to obtain additional contract
awards and to develop partnership opportunities; the timing of
commercial product launches; the ability to achieve key technical
milestones in key products; and other risk factors identified from time
to time in the company's SEC reports, including its Annual Report on
Form 10-K, and its Quarterly Reports on Form 10-Q.
